BioSpace News Archive

Adding advanced technology hardware to its portfolio, Flower One will offer Nevada cannabis retailers an increase in both supply and brand diversity of the popular G Pen vaporizer

BioArctic AB informs that Eisai today announced the timelines for the single confirmatory Phase 3 study with BAN2401 in early Alzheimer´s disease patients i.e. mild cognitive impairment due to Alzheimer’s disease or mild Alzheimer’s disease.

Dose-escalation study commences with first-in-class bispecific CTLA-4 antibody

LumiThera Inc. announced an agreement with Andrec Corporation S.A. to exclusively distribute the Valeda™ Light Delivery System for the treatment of dry age-related macular degeneration (AMD) in Colombia and several Latin America countries.

CASI Pharmaceuticals, Inc. announced that the National Medical Products Administration (NMPA) has approved the Company’s Clinical Trial Application (CTA) allowing for a registration clinical trial to evaluate the efficacy and safety of vincristine sulfate LIPOSOME injection (MARQIBO®).

SOM Biotech has just closed a financing round of 7 million euros led by a holding company belonging to a European family with a long tradition in the pharmaceutical sector which will give the opportunity to get a facilitated access to pharma network.

Akili to Create First-of-its-kind International Digital Medicine Development and Commercial Platform

Expedites Product Development and Provides Priority Regulatory Review For Paige.AI’s Pioneering Clinical-Grade Artificial Intelligence in Pathology

VolitionRx Limited announced it will host a conference call on Thursday, March 14 at 8:30 a.m. Eastern time to discuss its financial and operating results for the fourth quarter and full year 2018, in conjunction with the filing of its annual report on Form 10-K for the fourth quarter and full year ended December 31, 2018.

Booz Allen Hamilton Executive Brings Wide Array of Experience to ASYMCA Board